Correlation between Serum Markers of Adverse Left Ventricular Remodelling and Gene Expression Levels Measured in the Myocardial Tissue of Patients with Chronic Primary Mitral Regurgitation
Open Access
- 1 March 2020
- journal article
- research article
- Published by Wits University Press in Wits Journal of Clinical Medicine
- Vol. 2 (1) , 5-12
Abstract
Background: Chronic primary mitral regurgitation (CPMR) is characterized by progressive myocardial hypertrophy, fibrosis and dilatation. Although molecular markers of adverse left ventricular (LV) remodelling have been identified in the progression from compensated to decompensated heart failure in these patients, serum markers that could guide the optimal timing of intervention in these patients are still needed. Here we describe the correlation between the levels of expression of several genes important in adverse LV remodelling in CPMR and the serum levels of these markers. Methods: We performed echocardiography, cardiac catheterization, endomyocardial biopsy (EMB) and serum analysis in patients with severe CPMR during the preoperative workup for mitral valve surgery. Serum levels of N-terminal-pro hormone B-type natriuretic peptide, suppression of tumourigenicity 2, tumour necrosis factor α, Interleukin 6, FS-7-associated surface antigen (FAS), FAS ligand, matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP)-1 and TIMP-4 were determined using commercially available enzyme-linked immunosorbent assays. Myocardial levels of expression of the genes encoding these proteins were determined by multiplex gene expression analysis. Results: Serum and EMBs were obtained from 12 patients with CPMR at the time of preoperative cardiac catheterization. Overall, there was no significant correlation between the serum levels and gene expression levels for the markers evaluated in this study. A non-significant inverse correlation between serum MMP-2 and myocardial MMP-2 was noted (r = −0.343, P = 0.263). Conclusion: We found a poor correlation between the myocardial gene expression levels of several markers of adverse LV remodelling in patients with CPMR and the serum levels of these markers sampled at the same time.Keywords
This publication has 45 references indexed in Scilit:
- Left ventricular remodelling in chronic primary mitral regurgitation: implications for medical therapyCardioVascular Journal of Africa, 2018
- Mitral Regurgitation Due to Degenerative Mitral-Valve DiseaseNew England Journal of Medicine, 2010
- Tumor necrosis factor-α produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overloadJournal of Molecular and Cellular Cardiology, 2010
- Increased Oxidative Stress and Cardiomyocyte Myofibrillar Degeneration in Patients With Chronic Isolated Mitral Regurgitation and Ejection Fraction >60%JACC, 2010
- Forgotten cardiovascular diseases in AfricaClinical Research in Cardiology, 2009
- Perfil neuro-hormonal de pacientes reumáticos com insuficiência aórtica crônica importanteArquivos Brasileiros de Cardiologia, 2009
- Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-αAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral RegurgitationCirculation, 2003
- Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overloadJACC, 2000
- Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation.Circulation Research, 1992